Call Anytime 24 Hours - (888) 435-7001

Search
Do I Have A Case?
Firm Jury Verdicts
  • $1 Billion Verdict in Go-Kart Burn Case
  • $480 Million Verdict in Defective Single-Engine Aircraft
  • $380 Million Verdict in Environmental Case
  • $42 Million Verdict in Rezulin Case
  • $42 Million Verdict in Fraud/RICO Case
  • $31 Million Verdict in Medical Malpractice Case
  • $30 Million Verdict in Tobacco Case
  • $25 Million Verdict in Brain Injury Case
  • $22 Million Verdict in Brain Injury Case
  • $21 Million Verdict in Discrimination Case
  • $18 Million Verdict in Train Derailment
  • $13 Million Verdict in Automobile Accident
  • $11 Million Verdict in Dental Malpractice
  • $10 Million Verdict in Accutane Case
  • $10 Million Verdict in Asbestos Case
  • $10 Million Verdict in Breach of Contract Case
  • $9 Million Verdict in Tobacco Case
  • $9 Million Verdict in Brain Injury Case
  • $8 Million Verdict in Fosamax Case
  • $8 Million Verdict in DRAM Shop Case
  • $8 Million Verdict in Medical Malpractice
  • $7 Million Verdict Against Hartford Ins. Co.
  • $7 Million Verdict Auto-Owners Insurance Company
  • $5 Million Verdict in Airplane Crash

Video Player

Stevens-Johnson Syndrome (SJS) Information

BREAKING NEWS: Controversial drug Ketek may be linked to Stevens Johnson Syndrome

"A new procedure, should it prove to be successful, can be used to treat eyes destroyed by chemical agents such as acids, accidents that physically damage the cornea and even Stevens-Johnson syndrome. The cost of treatment is expected to be between Rs 20,000-25000." Click here to read more...

Although the cause isn't always clear, Stevens-Johnson syndrome usually is a specific type of allergic reaction in response to medication or infection. An emergency medical condition, Stevens-Johnson syndrome requires hospitalization. Treatment focuses on eliminating the underlying cause, if possible, controlling symptoms and minimizing complications. Recovery after Stevens-Johnson syndrome can take several weeks to several months, depending on the severity of your condition.

SJS can cause serious eye problems, such as severe conjunctivitis; iritis, an inflammation inside the eye; corneal blisters and erosions; and corneal holes. In some cases, the ocular complications from SJS can be disabling and lead to severe vision loss. The most commonly cited cause of SJS is an adverse allergic drug reaction. Almost any drug--but most particularly sulfa drugs--can cause SJS. The allergic reaction to the drug may not occur until 7-14 days after first using it. SJS can also be preceded by a viral infection, such as herpes or the mumps, and its accompanying fever, sore throat, and sluggishness. Treatment for the eye may include artificial tears, antibiotics, or corticosteroids. About one-third of all patients diagnosed with SJS have recurrences of the disease. SJS occurs twice as often in men as women, and most cases appear in children and young adults under 30, although it can develop in people at any age.


According to the Fall 2007 FDA Drug Safety Newsletter (Volume 1, Number 1), which was released in mid-September 2007, the FDA has been monitoring cases of serious skin reactions associated with the sleep disorder drug Provigil (modafinil). This medication, made by the drug company Cephalon, Inc., is prescribed to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea / hypopnea syndrome (OSAHS), and shift work sleep disorder.


NEXIUM has been linked to Stevens Johnson Syndrome and Toxic Epidermal Necrolysis

The safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in the United States and over 6,500 patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. Adverse events that were reported as possibly or probably related to NEXIUM include dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, and skin inflammation. Since being launched onto the open market and sold to unsuspecting, innocent consumers, post marketing reports have reports have been linked to both Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Some of the reactions have been fatal.


What is Stevens-Johnson Syndrome (SJS)? What are some SJS side effects?

Stevens-Johnson Syndrome (SJS) is an auto-immune, exfoliative disorder of the skin and the mucous membranes usually caused by an adverse drug reaction. It is characterized by an extremely painful blistering skin rash, peeling skin, and blistering sores in the mucous membranes including the eyes, mouth, nostrils, throat, and anal and genital areas. In the more severe forms of the disease, the skin peels off in sheets from large areas of the body, similar to a serious burn injury. The eyes are often badly affected. Stevens-Johnson Syndrome is often caused by an allergic reaction to a drug or medication. Bextra, the popular anti-inflammatory arthritis medication, as well as Daypro and Feldene have been associated with Stevens-Johnson Syndrome as have many other non-steroidal anti-inflammatory drugs (NSAIDs) such as Motrin. Sulfa-based antibiotics, some seizure medications and many other drugs have also been associated with SJS.

Adverse drug reactions are the 4th leading cause of death in North America.

Certain prescription pain relievers, including those from the COX-2 inhibitor class, such as Bextra (valdecoxib) and Celebrex (celecoxib), have also been associated with SJS and TEN. In 2002, the FDA received reports from Pharamcia, the maker of Celebrex, documenting a number of reported cases of SJS and TEN among Celebrex users. More recently, reports have surfaced about the relation of Bextra to SJS and TEN. Indeed, despite these reports and more stern warnings, the FDA continues to receive reports of SJS and TEN in patients taking Bextra and Celebrex. The FDA suggests that patients with sulfa drug allergies should not take these drugs.

Drug companies have a responsibility to protect their drug users from adverse reactions. While all potential side effects cannot be anticipated or prevented in all patients, it is important that patients and physicians have adequate knowledge to prevent as many cases of serious side effects, such as Stevens Johnson Syndrome or toxic epidermal syndrome, as possible. Since these drug side effects can cause debilitating injury or even death, the drug companies should be held responsible for the damages to the patient and to the patients' family members after such tragedies. SJS or TEN Lawsuits against drug makers for wrongful death or for negligence can help compensate the victims of these disorders and their families.


Drug reactions are one of the leading causes of death in the United States. However, less than one percent of adverse drug reactions are reported to the FDA because there is no mandatory reporting system in effect for post marketing adverse drug reactions. Once a drug goes to market there is little done to study and/or prevent adverse reactions. Because the information is not made available to doctors, they may misdiagnose drug-related TEN/ SJS reactions as something else, wasting precious time as the disease ravages its victims. In fact, many doctors do not recognize the signs and symptoms of Toxic Epidermal Necrolysis (TEN) or Stevens Johnson Syndrome (SJS) until it is too late. Unfortunately, for several reasons including inadequate warnings and lack of awareness, doctors continue to give victims of TEN / SJS more of the drug causing the life threatening reaction --doing more harm, which could end up killing patients. Consumers cannot rely upon the FDA, their own physician nor pharmaceutical companies manufacturing various drugs (i.e. "Big Pharma") to protect them from drug reactions.

For more information about SJS please visit www.sjsyndrome.com

Stevens Johnson Syndrome Lawsuits

If you or a loved one has been afflicted with Stevens Johnson Syndrome or Toxic Epidermal Necrolysis, then it is possible that the condition was caused by an allergic reaction to a drug. To determine whether the drug companies are liable for damages causing SJS or TEN and if you may be eligible for compensation, contact our Stevens Johnson Syndrome Lawyers for a case evaluation.

Our attorneys are experts in dealing with large drug companies and obtaining compensation for victims of SJS and TEN.


Stevens-Johnson Syndrome Frequently Asked Questions

  • What is Stevens Johnson Syndrome (SJS)?
  • What are the symptoms of Stevens Johnson Syndrome?
  • Does Bextra or Celebrex cause Stevens Johnson Syndrome?
  • What is Toxic Epidermal Necrolysis (TEN)?
  • What are the symptoms of Toxic Epidermal Necrolysis?
  • Does Bextra or Celebrex cause Toxic Epidermal Necrolysis?
  • What is Erythema Multiforme (EM)?
  • What is Erythema Multiforme Minor (EM Minor)?
  • What is Erythema Multiforme Major (EM Major)?
  • What is Exfoliative Dermatitis?
  • What other names does Stevens Johnson Syndrome go by?


What is Stevens Johnson Syndrome (SJS)?

Stevens Johnson Syndrome (SJS), also referred to as EM-major, is an immune-complex-mediated hypersensitivity condition (serious skin reaction) that is typically caused as an adverse reaction to certain drugs, like Bextra. It can, in its most severe form, be fatal; eliciting fatal results in approximately 3% to 15% of sufferers. It commonly causes swelling of the mouth, throat, anogenital region, intestinal tract, and the lining of the eyelids. Stevens Johnson Syndrome is viewed to be a more severe type of erythema multiforme (hence the EM-major classification) and typically affects people over the age of 40; however, SJS cases have been reported in children as young as three months old.

What are the symptoms of Stevens Johnson Syndrome?

People with Stevens Johnson Syndrome may have purplish or red lesions that may be flat or small and raised. The lesions may turn into fluid-filled blisters. Stevens Johnson syndrome can also cause blisters or bleeding in the mucous membranes of the lips, mouth, eyes, nasal passages, and genitals. If the affected membranes become infected, abnormalities in the affected area (especially the eyelids) may occur.

Does Bextra or Celebrex cause Stevens Johnson Syndrome?

Some researchers feel that Stevens Johnson Syndrome may be an allergic reaction to a drug, while others maintain it is its own syndrome. However, since there have been incidences of Stevens Johnson Syndrome in patients taking NSAIDs, like Bextra & Celebrex, it is likely these patients are having an allergic reaction to the COX-2 inhibitor drugs when they develop Stevens Johnson Syndrome.

What is Toxic Epidermal Necrolysis (TEN)?

Toxic epidermal necrolysis (TEN), also known as Lyell's Syndrome, is the most serious of the three related Stevens Johnson Syndrome skin diseases. It is characterized by involvement of more than 25 percent of a patient's skin as well as eruptions of the mucous membranes (mucosa). In this form of Stevens-Johnson Syndrome, the skin peels off in large sheets. Usually fever and feelings of ill-health are present. TEN resembles severe burn injuries all over the body and is fatal in up to one-third of cases. TEN can also be caused as an allergic reaction to certain drugs, like Bextra.

What are the symptoms of Toxic Epidermal Necrolysis?

People with toxic epidermal necrolysis develop blisters that cover 30% or more of their bodies. The skin peels and sloughs off in large amounts. The skin exposed by this sloughing is red and appears burned or scalded. The mucous membranes can be affected, especially those around the eyes. The mouth, throat, and mucous membranes of the lung may also be affected.

Does Bextra or Celebrex cause Toxic Epidermal Necrolysis?

Toxic epidermal necrolysis is believed to be an allergic reaction to drugs in the NSAID family, like Bextra & Celebrex. Bextra (valdecoxib) and Celebrex (celecoxib) are COX-2 inhibitor drugs that have been known to illicit SJS and/or TEN. Toxic epidermal necrolysis has been classified as an immunological disorder.

What is Erythema Multiforme (EM)?

Erythema multiforme (EM) is a type of skin condition that is characterized by the development of symmetrically raised red skin areas without displaying whole-body symptoms. EM is a condition that frequently occurs in children and young adults. It is the least severe of the three Stevens Johnson Syndrome related skin disorders.

What is Erythema Multiforme Minor (EM Minor)?

Erythema Multiforme Minor (EM Minor) is the milder form of Stevens-Johnson Syndrome. Known as EM-Minor or EM, this form includes acute skin eruptions, but usually does not involve the mucous membranes.

What is Erythema Multiforme Major (EM Major)?

Erythema Multiforme Major (EM Major), which is more technically Stevens-Johnson Syndrome (SJS) involves the mucous membranes, (most commonly the mouth and eyes) in addition to the skin. Usually fever and flu-like symptoms are present. Eye involvement is often quite serious, with blindness or other visual impairment resulting.

What is Exfoliative Dermatitis? Exfoliative Dermatitis is a generic description of the type of skin disease Stevens Johnson Syndrome patient's suffer from.

What other names does Stevens Johnson Syndrome go by? Other Names For Stevens Johnson Syndrome include: Dermatostomatitis, Stevens Johnson Type; Ectodermosis Erosiva Pluriorificialis; Erythema Multiforme Exudativum; Erythema Polymorphe, Stevens Johnson Type; Lyell's Syndrome; Febrile Mucocutaneous Syndrome, Stevens Johnson Type; Johnson-Stevens Disease.

Stevens-Johnson Syndrome Case Evaluation Form


Related Stevens-Johnson Syndrome News and Articles

  • August is Stevens Johnson Syndrome Awareness Month. I am asking for your assistance along with the SJS Foundation to have each state government, just as the United States, proclaim August to be Stevens Johnson Syndrome Awareness Month. Each the SJS Foundation and myself write to the United States Governors asking them to proclaim August SJS Awareness Month in their state. However many states want a letter from a local resident. Please help us by writing your state governor. A sample letter is available on the Stevens Johnson Syndrome Foundation website.
    * To access your Governor's address click here.
  • Stevens Johnson Syndrome Awareness Month -- August 2007
    The Stevens Johnson Syndrome (SJS) Foundation today announced that August 2007 has been designated SJS Awareness month...
  • Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome?
    Shen, Y.-C., et al. - As lamotrigine is currently licensed for the prophylactic treatment of bipolar depression, many of these patients have psychotic features where it would be considered reasonable to add an antimanic atypical antipsychotic such as aripriprazole.
  • In the pursuit of classifying severe cutaneous adverse reactions
    Wolf, R., et al. - We suggest adding an additional type of lesion to the existing 4 types of lesions of the erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), namely "flat typical target" and call the original typical targets "raised typical target." The EM group would consist of raised typical targets and raised atypical targets, similar to the original definition, and the SJS/TEN group would consist of flat typical targets, flat atypical targets and macules with or without blisters
  • Nuvigil Wins U.S. Approval - Treatment For Obstructive Sleep Apnea/hypopnea Syndrome (OSAHS), Narcolepsy, And Shift- Work Sleep Disorder
    MedicalNewsToday.com - June 21, 2007
    Cephalon Inc. announced that it has received U.S. marketing approval for armodafinil, or Nuvigil, an oral medication indicated to treat adults with excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSAHS), narcolepsy, and shift- work sleep disorder (SWSD). Read full article.
  • FDA Approves Cephalon's Sleep-Disorder Drug Nuvigil
    Cephalon is celebrating after US regulators at last gave the green light to Nuvigil, its new compound for excessive sleepiness and a longer-acting version of its biggest earner Provigil.

    The US Food and Drug Administration has approved the non-amphetamine wake-promoting agent Nuvigil (armodafinil) for the treatment of excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome, narcolepsy, and shift work sleep disorder. The decision comes a year after the FDA delayed approval of Nuvigil over a problem with labelling, which was complicated by the agency's review of another product based on modafinil, Sparlon for attention-deficit hyperactivity disorder.
  • Controversial drug Ketek may be linked to Stevens Johnson Syndrome
    Sanofi Aventis, one of the largest drug manufacturers in the world, is now considering another label change to its ever controversial drug Ketek (telithromycin). Ketek is an antibiotic that is commonly prescribed to help the body fight off infection caused by bacteria and has recently drawn criticism for its documented link to severe liver damage in its consumers. After learning of a Canadian woman who suffered a severe allergic reaction to Ketek called Toxic Epidermal Necrolysis (TEN) , Sanofi Aventis is now considering a change on its label that would warn potential consumers and physicians of other side effects such as Stevens Johnson Syndrome (SJS) and TEN. As a drug class, Antibiotics (like Ketek) cause victims to suffer from TEN / SJS reactions more than most all other drugs. Adverse drug reactions are the fourth leading cause of death in North America and the mortality rate (i.e. death rate) associated with TEN and SJS reactions is reported to be as high at 70% and 35% respectively.
  • Antibiotic under review amid safety warnings
    Sharon Kirkey - CanWest News Service - May 07, 2007
    26-year-old developed toxic epidermal necrolysis, an extremely rare drug reaction where people essentially shed the outer protective layer of their skin.
  • Family of woman who died after skin fell off files suit
    The Tennessean, TN - May 1, 2007
    Rees was rushed to Baptist Hospital on May 6, 2006, and doctors there immediately suspected that she had Stevens Johnson Syndrome, a severe skin reaction ...
  • Large Numbers of People Do Not Trust the Institutions They Identify as Most Responsible for Drug Safety
    ROCHESTER, N.Y., April 25, 2007 /PRNewswire/ -- In a survey conducted by Harris Interactive(R), people were asked for their opinions regarding institutions responsible for drug safety in the United States. We found that institutions believed to have the greatest responsibility in drug safety are often those that are least trusted to do so. Among a list of four entities integral to drug safety -The Federal Drug Administration (FDA), pharmaceutical companies, doctors and other healthcare providers, and Congress - people identified the FDA and pharmaceutical companies as the entities that should bear the most responsibility for drug safety in the United States today. ...
  • Dr. Curt Furberg, a member of the Food and Drug Administration's Drug Safety and Risk Management Advisory Committee and a leading authority on drug trials, said in a commentary that the FDA has required that safety warnings be added to drugs that are safe and failed to restrict drugs that aren't. View Full Article (PDF)
  • Eye treatment breaks new ground
    Daily News & Analysis - Mumbai, India
    ...can be used to treat eyes destroyed by chemical agents such as acids, accidents that physically damage the cornea and even Stevens-Johnson syndrome. ...
  • Givers of Hope
    Taiwan Review
    Researchers in Taiwan have worked to identify the genetic markers that cause severe adverse drug reactions. A genetic marker is a gene or DNA sequence having a known location on a chromosome and associated with a particular gene or trait. Each year 50 to 60 cases relating to adverse drug reactions like Stevens-Johnson Syndrome are reported in Taiwan. They are deadly, but could be prevented. Recently, scientist in Taiwan successfully identified the gene marker, HLA-B *1502, for carbamazepine, commonly used to treat epilepsy and neuralgia.
  • Stevens-Johnson syndrome - MayoClinic.com
    Stevens-Johnson syndrome — Comprehensive overview covers signs, symptoms, diagnosis, treatment of this severe skin disorder.
  • Bactrim and SJS
    An investigation by Brian Deer for The Sunday Times of London over side-effects and risks from the antibiotic known as Bactrim, Septra, Septrin, smz-tmp, Sulfatrim, co-trimoxazole, and many other names. For more information about the horrible skin reactions, go to http://briandeer.com/bactrim-septra.htm.
  • Sulfa Allergy Leads to Man's Development of Stevens Johnson Syndrome
    One man's battle with Stevens Johnson Syndrome was traced back to the use of an antibacterial drug called Sulfa that he had been administered to help avoid an infection. He was diagnosed with Stevens Johnson Syndrome in 1996. »Read more
  • Children Victimized by Stevens Johnson Syndrome
    Although Stevens Johnson Syndrome (SJS) is typically associated with adults over the age of 40, it is not uncommon for the severe skin disease to affect children as young as three months old. The following account is of four year old girl who was victimized by Stevens Johnson Syndrome. »Read more
  • 'What's a Foot for a Life?'
    Imagine for a moment that an unknown medical problem causes you to lose consciousness; when you wake, you're missing a limb. How would you react? The following account details the story of a 23-year old woman from Brisbane, Australia and her reaction to this scenario. »Read more

Stevens Johnson Syndrome Lawsuits

If you or a loved one has been afflicted with Stevens Johnson Syndrome or Toxic Epidermal Necrolysis, then it is possible that the condition was caused by an allergic reaction to a drug. To determine whether the drug companies are liable for damages causing SJS or TEN and if you may be eligible for compensation, contact our Stevens Johnson Syndrome Lawyers for a case evaluation.

Our attorneys are experts in dealing with large drug companies and obtaining compensation for victims of SJS and TEN.